MedTech Outlook Magazine: Specials Magazine

What clinical problem in lumbar degeneration motivated development of the Restore device? In the initial stages of development, Dr. Sturm was asked, “So, what is this thing? What is it supposed to do?”, after completing his presentation of “Restore”, a completely novel and innovative spinal device, to a group of spinal instrumentation company executives. The engineer in the audience chimed in, “It’s the ‘Holy Grail of Spine’, If you can get it to work…” Well, Facet Dynamics, Inc. did just that, they “got it to work”… Lumbar degenerative disease remains one of the most prevalent and costly conditions in modern healthcare. It consistently ranks among the top expenditures in U.S. healthcare spending, reflecting both its frequency and the enduring realities of human biomechanics. As Dr. Chris D. Sturm, whose groundbreaking work in spinal surgery offers an innovative solution, “Restore”—the Emerging Lumbar Facet Joint Replacement Device—explains, lumbar degeneration is not a problem that will disappear. Human beings are upright organisms living under constant gravitational load. The motion segments of the spine—each composed of a disc and paired facet joints—are stacked in a configuration that allows movement to dissipate force. When that system deteriorates, pain and neurological compromise follow. For nearly eighty years, lumbar fusion has been the primary surgical solution for many degenerative conditions requiring stabilization. Fusion achieves stability by eliminating motion at the affected level. Yet the spine was designed to move. Each motion segment contributes to a cascade of load distribution. When motion is arrested at one level, force is transferred to adjacent segments, accelerating degeneration in those regions. This phenomenon, commonly referred to as adjacent segment disease, is a well-recognized clinical reality. Many patients who undergo fusion ultimately require additional surgery above or below the original construct. Public perception reflects this biomechanical tension. While fusion remains the standard of care in many situations, it carries a reputation for sacrificing natural motion. Artificial lumbar disc technology attempted to address this concern, but its primary contraindication—facet joint degeneration—limits eligibility for the overwhelming majority of surgical candidates. According to Dr. Sturm, facet degeneration is present in approximately ninety-eight percent of patients who would otherwise qualify for disc replacement. As a result, the posterior facet joint has emerged as a critical driver of the projected $18.2 billion lumbar spine market by 2030, with roughly eighty-five percent of that market influenced by facet-related pathology. Within this landscape, Facet Dynamics has developed an investigational unilateral lumbar facet joint replacement system designed to provide stability while preserving motion. The device is not yet approved for commercial use and remains in the regulatory and investigational phase. Its development has included bench testing, cadaveric evaluation, and structured consultation with the U.S. Food and Drug Administration. Regulatory clarity has been central to the company’s progression.

How does EvoSkin address structural aging at the subdermal level? EvoSkin, a boutique medical innovator in aesthetic technology, approaches non-surgical aesthetics through an inside-out treatment philosophy that targets structural tissue at the subdermal level, where laxity and age-related change originate. With ENDO-ONE, the company addresses a core limitation of many energy-based devices focused primarily on surface effects. The platform delivers consistent clinical outcomes while enabling scalable workflows across rooms, providers and locations. Guided by a physician-driven management and R&D team, EvoSkin works closely with medical aesthetic clinics and physicians globally, grounding product development and partnerships in clinical insight. ENDO-ONE reflects this clinical foundation through precision, biological respect and versatility. Clinically, it allows physicians to work precisely within connective tissue and adipose layers using an ultra-thin optical fiber. This enables effective tissue tightening and remodeling, with selective adipose interaction and minimal tissue trauma. For clinicians, this translates into natural-looking results and a high safety profile, a key factor in building long-term trust. Controlled, repeatable energy delivery ensures consistent, realistic outcomes across patients and anatomical areas. What role does dual-wavelength technology play in controlled tissue remodeling? Central to this performance is ENDO-ONE’s dual-wavelength diode fiber technology. By combining wavelengths with different tissue affinities, the system selectively targets connective tissue, water-rich structures and adipose layers within a single platform..

Why does dental sleep care require interdisciplinary precision and coordination? Dental sleep care sits at the intersection of dentistry and medicine, where airway health, joint stability, and long-term patient compliance must align for treatment to succeed. Every patient deserves precise care that goes beyond just fitting an appliance—it's about crafting a solution that enhances their quality of life and well-being. This is where Diamond Orthotic Lab plays a pivotal role. Each case relies on meticulous records, clear therapeutic intent, and personalized fabrication that reflect each patient's clinical reality. Early decisions shape outcomes, timelines, and patients' confidence in their treatment, well before an appliance reaches them. “We don’t just manufacture appliances. The real value is helping clinicians reduce variability and achieve predictable outcomes. At the end of every device is a patient, and that responsibility drives everything we do,” says Matt Rago, CEO and co-founder..